Everest Medicines Ltd. is a biopharmaceutical company primarily focused on the development and commercialization of transformative pharmaceutical products. Its primary aim is to address critical unmet... Everest Medicines Ltd. is a biopharmaceutical company primarily focused on the development and commercialization of transformative pharmaceutical products. Its primary aim is to address critical unmet medical needs in Asian markets, with an emphasis on oncology, kidney diseases, infectious diseases, and autoimmune disorders. Everest Medicines leverages partnerships with global biopharmaceutical companies to in-license innovative drugs and technology, facilitating the introduction of advanced medical therapies in the region. Notably, it impacts key areas such as cancer treatment and disease management, contributing to the health sectors in fast-growing Asian economies. The company’s strategic activities underscore its significance in driving the availability of cutting-edge medical solutions and elevating healthcare standards across its target markets.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Everest Medicines is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Everest Medicines is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Everest Medicines's data?

Start your 30-day free trial to request a data review for Everest Medicines.

Start Free Trial

Legal Center Contact Us